Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
Capstick TGD, Hopkinson NS. Int J Chron Obstruct Pulmon Dis. 2021;16:2917–2923. The authors have advised there are minor errors in Table 2 on pages 2920–2921. The correct Table 2 is shown in Download Article. The authors apologize for these errors and advise they do not affect th...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/665a780def7f4f83a834cce2eb97a521 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:665a780def7f4f83a834cce2eb97a521 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:665a780def7f4f83a834cce2eb97a5212021-11-30T18:50:37ZAdapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]1178-2005https://doaj.org/article/665a780def7f4f83a834cce2eb97a5212021-11-01T00:00:00Zhttps://www.dovepress.com/corrigendum-adapting-inhaled-medication-practice-in-copd-and-asthma-to-peer-reviewed-fulltext-article-COPDhttps://doaj.org/toc/1178-2005Capstick TGD, Hopkinson NS. Int J Chron Obstruct Pulmon Dis. 2021;16:2917–2923. The authors have advised there are minor errors in Table 2 on pages 2920–2921. The correct Table 2 is shown in Download Article. The authors apologize for these errors and advise they do not affect the results of the paper. Read the original articleCapstick TGDHopkinson NSDove Medical Pressarticleethicscorporate social responsibilitypublic healthDiseases of the respiratory systemRC705-779ENInternational Journal of COPD, Vol Volume 16, Pp 3239-3241 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
ethics corporate social responsibility public health Diseases of the respiratory system RC705-779 |
spellingShingle |
ethics corporate social responsibility public health Diseases of the respiratory system RC705-779 Capstick TGD Hopkinson NS Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum] |
description |
Capstick TGD, Hopkinson NS. Int J Chron Obstruct Pulmon Dis. 2021;16:2917–2923.
The authors have advised there are minor errors in Table 2 on pages 2920–2921. The correct Table 2 is shown in Download Article.
The authors apologize for these errors and advise they do not affect the results of the paper.
Read the original article |
format |
article |
author |
Capstick TGD Hopkinson NS |
author_facet |
Capstick TGD Hopkinson NS |
author_sort |
Capstick TGD |
title |
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum] |
title_short |
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum] |
title_full |
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum] |
title_fullStr |
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum] |
title_full_unstemmed |
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum] |
title_sort |
adapting inhaled medication practice in copd and asthma to avoid funding the tobacco industry [corrigendum] |
publisher |
Dove Medical Press |
publishDate |
2021 |
url |
https://doaj.org/article/665a780def7f4f83a834cce2eb97a521 |
work_keys_str_mv |
AT capsticktgd adaptinginhaledmedicationpracticeincopdandasthmatoavoidfundingthetobaccoindustrycorrigendum AT hopkinsonns adaptinginhaledmedicationpracticeincopdandasthmatoavoidfundingthetobaccoindustrycorrigendum |
_version_ |
1718406328013029376 |